2024

GAIA, introduced KETO-OME—a dual-action innovative formulation combining ketoprofen for pain and inflammation relief with omeprazole for gastric protection. Developed to minimize gastrointestinal side effects commonly linked to NSAIDs, KETO-OME progressed through formulation, regulatory approval, and branding, leading to its successful market launch.